๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Life span prolongation effect of lentinan on patients with advanced or recurrent breast cancer

โœ Scribed by T. Taguchi; O. Abe; K. Enomoto; S. Kusama; J. Tomiyama; K. Tominaga; N. Ogawa

Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
76 KB
Volume
4
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of timing of metastasis/disease r
Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer
โœ Pooja R. Patel; James C. Yao; Kenneth Hess; Isac Schnirer; Asif Rashid; Jaffer A ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB

## Abstract ## BACKGROUND. Patients with advanced gastric cancer have a median survival (MS) of <9 months. It is unclear whether the MS of patients who have advanced cancer at the time of diagnosis (synchronous, Group A) is different from that for patients who develop advanced cancer after curativ

Predictors of recurrence for patients wi
Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T 1 a,b NO MO)
โœ Stuart P. Leitner; Arlene S. Swern; Daniela Weinberger; Lesley J. Duncan; Robert ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 849 KB

Background. The frequency of small (5 1 cm) axillary lymph node negative invasive breast cancers (Tla,b NO MO) is increasing because of wider implementation of breast cancer screening. Identification of prognostic factors for these patients has been based largely on retrospective pathology review. T

Exploratory analysis on the effect of ra
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues
โœ McLeod, David G.; Schellhammer, Paul F.; Vogelzang, Nicholas J.; Soloway, Mark S ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 2 views

## BACKGROUND. Black race has been associated with a significantly increased risk of prostate cancer mortality. This exploratory analysis investigated the effect of race on the clinical outcome of combined androgen blockade (CAB). METHODS. Data for analysis were obtained from a double-blind, rando